Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravindra Majeti

Showing results (1-10 of 154) with videos related to

Pageof 16
Sort By:
Best Practice & Research. Clinical Haematology|December 3, 2014
Clonal evolution of pre-leukemic hematopoietic stem cells precedes human acute myeloid leukemiaRavindra Majeti
Cancer Cell|November 16, 2016
Sticking It to the Niche: CD98 Mediates Critical Adhesive Signals in AMLAndreas Reinisch, Ravindra Majeti
Cell Stem Cell|June 24, 2010
Metastatic cancer stem cells: an opportunity for improving cancer treatment?Maximilian Diehn, Ravindra Majeti
International Journal of Hematology|November 1, 2016
The role of mutations in the cohesin complex in acute myeloid leukemiaClaire Mazumdar, Ravindra Majeti
Cancer Discovery|May 3, 2017
Optimizing Next-Generation AML Therapy: Activity of Mutant IDH2 Inhibitor AG-221 in Preclinical ModelsDaniel Thomas, Ravindra Majeti
Blood|February 5, 2017
Biology and relevance of human acute myeloid leukemia stem cellsDaniel Thomas, Ravindra Majeti
Cancer Cell|March 20, 2019
No Matter How You Splice It, RBM39 Inhibition Targets Spliceosome Mutant AMLRozario Thomas, Ravindra Majeti
Blood|January 15, 2026
Resistance is not futile: RAS inhibition resensitizes AMLCailin Collins, Ravindra Majeti
Cell Stem Cell|July 9, 2016
Burning Fat Fuels Leukemic Stem Cell HeterogeneityDaniel Thomas, Ravindra Majeti
Cancer Discovery|August 19, 2021
Clonal Hematopoiesis: From Mechanisms to Clinical InterventionThomas Köhnke, Ravindra Majeti
Pageof 16

Showing results (1-10 of 154) with videos related to

Sort By:
Pageof 16
Best Practice & Research. Clinical Haematology|December 3, 2014
Clonal evolution of pre-leukemic hematopoietic stem cells precedes human acute myeloid leukemiaRavindra Majeti
Cancer Cell|November 16, 2016
Sticking It to the Niche: CD98 Mediates Critical Adhesive Signals in AMLAndreas Reinisch, Ravindra Majeti
Cell Stem Cell|June 24, 2010
Metastatic cancer stem cells: an opportunity for improving cancer treatment?Maximilian Diehn, Ravindra Majeti
International Journal of Hematology|November 1, 2016
The role of mutations in the cohesin complex in acute myeloid leukemiaClaire Mazumdar, Ravindra Majeti
Cancer Discovery|May 3, 2017
Optimizing Next-Generation AML Therapy: Activity of Mutant IDH2 Inhibitor AG-221 in Preclinical ModelsDaniel Thomas, Ravindra Majeti
Blood|February 5, 2017
Biology and relevance of human acute myeloid leukemia stem cellsDaniel Thomas, Ravindra Majeti
Cancer Cell|March 20, 2019
No Matter How You Splice It, RBM39 Inhibition Targets Spliceosome Mutant AMLRozario Thomas, Ravindra Majeti
Blood|January 15, 2026
Resistance is not futile: RAS inhibition resensitizes AMLCailin Collins, Ravindra Majeti
Cell Stem Cell|July 9, 2016
Burning Fat Fuels Leukemic Stem Cell HeterogeneityDaniel Thomas, Ravindra Majeti
Cancer Discovery|August 19, 2021
Clonal Hematopoiesis: From Mechanisms to Clinical InterventionThomas Köhnke, Ravindra Majeti
Pageof 16